Cardiovascular Disease and T2D: Defining the link between T2D and Heart Failure
Topic:
Cardiovascular Disease and T2D: Defining the link between T2D and Heart Failure
Objectives:
- Describe the link between T2D and HF and review diabetic / non-diabetic cardiomyopathy
- Discuss clinical perspectives on HFpEF and HFrEF.
- Understand approved treatment options for HF in patients with T2D and without diabetes patients
- Describe the effects of SGLT2 inhibition in the prevention and treatment of HF
Speaker:
Rachelle Richner, MSN, CRNP, NP-C
This webinar is brought to you through a partnership with AstraZeneca.